Clinical Trials Insight: 700043711
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2009
At a glance
- Drugs Radequinil (Primary)
- Indications Dementia
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 23 Apr 2009 New trial record.
- 17 Apr 2009 Based on results of a phase II trial in the US (see trial profile 700031303), Dainippon Sumitomo Pharma has discontinued development of this compound both in Europe and abroad, according to a Dainippon Sumitomo Pharma media release.